Guard Therapeutics International AB (publ)
Swedish biotech developing novel kidney disease therapies based on proprietary peptides.
Overview
- 5–9
- Employees
- ≤1K SEK
- Revenue
- 2008
- Founded
Description
Guard Therapeutics is a Swedish clinical-stage biotechnology company dedicated to developing novel therapies for kidney diseases, addressing significant unmet medical needs. The company's drug candidates are uniquely based on the body's own protein, alpha-1-microglobulin. Their lead candidate, RMC-0...